Navigation Links
Two are better than one

and, when chemotherapy is used in combination with the immunotherapy, it dies.

According to Sela, the study sheds light on the synergy at work in the antibody-receptor therapy system. The results demonstrate that with the right combination of antibodies, receptor degradation is accelerated: it's more than three times as effective as a single antibody in inhibiting HER2 signaling.

"Understanding how HER receptor degradation works could enhance weak therapeutic efficacy, as well as provide ways to sensitize patients to overcome inherent or acquired resistance to cancer treatment," says Yarden.

Prof. Yosef Yarden's research is supported by the Y. Leon Benoziyo Institute for Molecular Medicine; the Dolfi and Lola Ebner Center for Biomedical Research; the J & R Center for Scientific Research; the Aharon Katzir-Katchalsky Center; the M.D. Moross Institute for Cancer Research; the Willner Family Center for Vascular Biology; the Batsheva De Rothschild Foundation; Dr. Marvin Klein, Farmington Hills, MI; Mr. & Mrs. Bram Laub, Belgium; and the Herbert J. Seligmann Charitable Trust. Prof. Yarden is the incumbent of the Harold and Zelda Goldenberg Professorial Chair in Molecular Cell Biology.

Prof. Michael Sela's research is supported by the Y. Leon Benoziyo Institute for Molecular Medicine, and the Dolfi and Lola Ebner Center for Biomedical Research. Prof. Sela is the incumbent of the W. Garfield Weston Professorial Chair of Immunology.


'"/>

Source:Weizmann Institute


Page: 1 2

Related biology news :

1. Chemists create Superbowl molecule; May lead to better health
2. Protein discovery could unlock the secret to better TB treatment
3. Signaling protein builds bigger, better bones in mice
4. Harnessing microbes, one by one, to build a better nanoworld
5. Discovery may lead to better Candidiasis drug
6. Insects, viruses could hold key for better human teamwork in disasters
7. Atmosphere may cleanse itself better than previously thought
8. Could better mangrove habitats have spared lives in the 2004 tsunami?
9. Muscle repair: Making a good system better, faster; implications for aging, disease
10. Plant genes identified that can form basis for crops better adapted to environmental conditions
11. Building a better mouse model of lung cancer: FHIT counts
Post Your Comments:
*Name:
*Comment:
*Email:
TAG: Two are better than one

(Date:6/18/2013)... Kingdom, the Energy Department,s National Renewable Energy Laboratory ... published a paper describing a novel cellulose-degrading enzyme ... , commonly known as the gribble. , ... relatively unique ability to produce their own enzymes ... the biomass they eat. New biomass-degrading enzymes from ...
(Date:6/18/2013)... Scientists are expecting a very large "dead zone" in ... hypoxic level in the Chesapeake Bay this year, based ... the University of Michigan, Louisiana State University, and the ... year,s Gulf of Mexico hypoxic "dead" zone will be ... it among the ten largest recorded. That would range ...
(Date:6/18/2013)... June 18, 2013 Joshua Obar, Ph.D., Department of ... honored with a 2013 ICAAC Young Investigator Award for ... immunological memory responses to infection. , Obar earned ... 2001 and went on to complete his Ph.D. in ... He performed his Ph.D. thesis research in Edward Usherwood,s ...
Breaking Biology News(10 mins):Novel enzyme from tiny gribble could prove a boon for biofuels research 2NOAA, partners predict possible record-setting deadzone for Gulf of Mexico 2NOAA, partners predict possible record-setting deadzone for Gulf of Mexico 3NOAA, partners predict possible record-setting deadzone for Gulf of Mexico 4The American Society for Microbiology honors Joshua Obar 2
... compensate for a lazy partner by working harder to bring up ... lack of parenting, says research by bird biologists at the University ... parents to be involved in raising young, but it is very ... wanted to find out why, for some animals, parents stick together. ...
... UK national genome centre is being officially opened today ... Sir John Sulston and the Lord-Lieutenant of Norfolk. ... capacity in genomics - the science of understanding the ... exist between individuals. This knowledge can then be used ...
... of a unique science learning program developed by The ... increases in interest and achievement scores compared to other ... study are published in the June issue of the ... The program, HEADS UP (Health Education ...
Cached Biology News:Battle of the sexes benefits offspring, says research 2New national genome center launched 2New national genome center launched 3UT multimedia program increases middle school interest in science 2
(Date:6/18/2013)... Israel , June 18, 2013 ... Pharmaceutical Ingredients (APIs), generic and innovative intermediates, and finished dosage ... the company has been granted a United States ... US and Europe for the oral ... 8,410,176 B2 is titled Intermediate Compounds and Processes for ...
(Date:6/18/2013)... June 18, 2013 ... announced the addition of the "Injectable ... & Nanoparticles], Devices [Disposables & Reusable, Fillable ... Injectors] & Therapeutics [Diabetes & Oncology] - ... their offering.      (Logo: http://photos.prnewswire.com/prnh/20130307/600769) ...
(Date:6/18/2013)... Though health care jobs continued to ... Bureau of Labor Statistics -- the increase was far below ... new health care jobs were added in home health care ... of 6,000 jobs. Overall, the U.S. unemployment rate stayed flat ... Christmas reported that a total of just over 36,000 job ...
(Date:6/18/2013)... Earlier this year, Google announced the new ‘enhanced campaign’ ... impacts the core component of the product, the campaign, many ... updates since its inception in October of 2000. The ... very informative article on the subject.. , Google ... enhanced campaigns . Only recently, a date of July ...
Breaking Biology Technology:Mapi Pharma Granted United States Patent for Pain Relief Medication "Tapentadol" 2Injectable Drug Delivery Market by Formulations, Devices & Therapeutics - Global Forecasts to 2017 2Injectable Drug Delivery Market by Formulations, Devices & Therapeutics - Global Forecasts to 2017 3MedZilla Employment Report for June 2013 -- Jobs in Health Care Grow, But at Slower Pace 2MedZilla Employment Report for June 2013 -- Jobs in Health Care Grow, But at Slower Pace 3Core and More Technologies Helps Organizations Migrate to Google’s Enhanced Campaign Structure 2Core and More Technologies Helps Organizations Migrate to Google’s Enhanced Campaign Structure 3
... R.I., Oct. 21 Neurotech Pharmaceuticals,Inc., a ... of,sight-saving therapeutics for chronic retinal diseases, announced ... GMP manufacturing facility in,Cumberland, Rhode Island., ... Development Corporation,(RIEDC) and its financing programs, Rhode ...
... further notice, RICHMOND, Va., Oct. 21 Insmed Inc. ... on Thursday, October 16, 2008 NASDAQ issued a notice that:, ... enforcement of the rules requiring ... immediately, NASDAQ has also suspended the enforcement of the ...
... -Laureate to Manufacture Tolerx,s TRX518 Antibody, ... Inc., a full-,service biopharmaceutical development and protein ... into a cGMP contract manufacturing agreement,with Tolerx, ... discovery and,development of novel therapies for the ...
Cached Biology Technology:Neurotech Announces the Opening of Its GMP Manufacturing Facility in Cumberland, Rhode Island 2Neurotech Announces the Opening of Its GMP Manufacturing Facility in Cumberland, Rhode Island 3Neurotech Announces the Opening of Its GMP Manufacturing Facility in Cumberland, Rhode Island 4Insmed Announces That NASDAQ Temporarily Suspends Minimum Bid Closing Price Rule 2Insmed Announces That NASDAQ Temporarily Suspends Minimum Bid Closing Price Rule 3Laureate Announces Manufacturing Agreement with Tolerx 2
... turntable. Provides up to 30 minutes of walkaway time. Automatic Calibration. Five minute ... RS-232 port. ... ... ...
2,4,6-Trinitrophenyl hapten is conjugated to Bovine Gamma Globulin (BGG) through lysine by amide bonds....
Adhesive seal-tab, for HybriWell™ hybridization sealing system *set of 400*...
...
Biology Products: